Voya Investment Management LLC Acquires 59,544 Shares of The Cooper Companies, Inc. $COO

Key Points

• Voya Investment Management LLC increased its holdings in The Cooper Companies by 33.5%, acquiring an additional 59,544 shares, bringing its total to 237,239 shares valued at approximately $20 million.
• Analysts have issued mixed ratings on Cooper Companies, with target prices ranging from $72.00 to $105.00, and an average price target of $86.64 reflecting a "Moderate Buy" rating.
• Shares of Cooper Companies have seen a decline of 2.6%, with the stock currently trading at $66.68, significantly below its 52-week high of $112.38.

Voya Investment Management LLC grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 33.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 237,239 shares of the medical device company's stock after acquiring an additional 59,544 shares during the period. Voya Investment Management LLC owned about 0.12% of Cooper Companies worth $20,011,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of COO. JPMorgan Chase & Co. boosted its holdings in Cooper Companies by 3.4% in the 1st quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company's stock worth $436,681,000 after buying an additional 172,485 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock worth $399,340,000 after buying an additional 686,751 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in Cooper Companies by 12.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company's stock worth $333,595,000 after buying an additional 425,400 shares during the period. Millennium Management LLC boosted its holdings in Cooper Companies by 36.0% in the 1st quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company's stock worth $217,405,000 after buying an additional 682,166 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Cooper Companies by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company's stock worth $178,977,000 after purchasing an additional 284,943 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Trading Up 2.0%

COO stock traded up $1.36 during mid-day trading on Friday, reaching $68.58. The company had a trading volume of 961,352 shares, compared to its average volume of 2,296,118. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The company has a market capitalization of $13.63 billion, a PE ratio of 33.64, a price-to-earnings-growth ratio of 1.69 and a beta of 0.97. The firm has a 50 day moving average of $70.79 and a 200 day moving average of $75.31. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $111.44.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has initiated a share buyback plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board believes its shares are undervalued.

Insider Activity at Cooper Companies

In related news, COO Gerard H. Warner III bought 1,450 shares of the company's stock in a transaction on Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the purchase, the chief operating officer directly owned 18,319 shares of the company's stock, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Daniel G. Mcbride bought 3,000 shares of the company's stock in a transaction on Tuesday, September 2nd. The stock was bought at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the purchase, the chief operating officer directly owned 63,120 shares in the company, valued at approximately $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 15,975 shares of company stock valued at $1,079,566 over the last 90 days. 1.98% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

COO has been the topic of several research analyst reports. Piper Sandler decreased their price target on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a research note on Thursday, August 28th. Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the stock an "equal weight" rating in a research note on Thursday, August 28th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Wells Fargo & Company decreased their price target on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating on the stock in a research note on Thursday, August 28th. Finally, Loop Capital set a $100.00 price target on shares of Cooper Companies in a research note on Tuesday, June 17th. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Cooper Companies has an average rating of "Moderate Buy" and an average target price of $86.64.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.